Get started
Author

J. Michel

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
1995 · M Paesmans, J P Sculier, et al. · Journal of Clinical Oncology · 386
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.
1986 · J Klastersky, J P Sculier, et al. · Journal of Clinical Oncology · 135
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
1997 · M Paesmans, J.P Sculier, et al. · European Journal of Cancer · 83
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
1993 · J P Sculier, M Paesmans, et al. · Journal of Clinical Oncology · 78
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
1996 · J P Sculier, M Paesmans, et al. · Journal of Clinical Oncology · 71
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
2001 · for the European Lung Cancer Working Party, J P Sculier, et al. · British Journal of Cancer · 67
Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
1983 · J Klastersky, J P Sculier, et al. · PubMed · 32
Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors
1975 · J. Hildebrand, J. Brihaye, et al. · European Journal of Cancer (1965) · 32
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
1996 · M. Borges, J.P. Sculier, et al. · Lung Cancer · 30
Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors—A preliminary report
1973 · J. Hildebrand, J. Brihaye, et al. · European Journal of Cancer (1965) · 30
Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer
2015 · P. Van Houtte, J. Klastersky, et al. · Antibiotics and chemotherapy/Antibiotica et chemotherapia · 28
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer
1990 · J.P. Sculier, J. Klastersky, et al. · Annals of Oncology · 28
PDF
Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)
1985 · J. Klastersky, J. P. Sculier, et al. · Cancer · 27
Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting
1994 · S. J.-P. Van Belle, L. Stamatakis, et al. · Annals of Oncology · 20
PDF
Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
1976 · G De Wasch, J Bernheim, et al. · PubMed · 20
A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer
1990 · J.P. Sculier, J. Klastersky, et al. · Lung Cancer · 19
Adjuvant immunotherapy by levamisole in resectable lung cancer: A control study
1980 · P. Van Houtte, H. Bondue, et al. · European Journal of Cancer (1965) · 19
Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancer
1990 · J.P. Sculier, J. Klastersky, et al. · European Journal of Cancer and Clinical Oncology · 15
Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. A randomized study of the Belgian Society of Medical Oncology.
1986 · R Paridaens, D Becquart, et al. · PubMed · 9
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer
1990 · R. Paridaens, C. Focan, et al. · Cancer Chemotherapy and Pharmacology · 8
Hodgkins' disease with massive hepatic involvement and uninvolved spleen
1973 · J. Michel, D. Ardichvili, et al. · European Journal of Cancer (1965) · 5
Phase II trial with chlorozotocin in advanced colorectal cancer
1981 · H. Bleiberg, M. Rozencweig, et al. · European Journal of Cancer and Clinical Oncology · 4
Thrombocytosis, Methotrexate, and Citrovorum Factor
1970 · Y. Kenis, J. Michel, et al. · The Lancet · 4
Phase II trial of fotemustine in advanced colorectal cancer
1990 · H. Bleiberg, D. Becquart, et al. · European Journal of Cancer and Clinical Oncology · 3
[Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results].
1986 · J P Sculier, J Klastersky, et al. · PubMed · 1
Works count: 25
Citation count: 1,154
H-index: 17
I10-index: 18
Year
Topic
Type